In an accompanying editorial, the authors note that the study had several strengths including its large sample size, small amount of missing data, and ability to account for multiple potential confounders. However, they argued against routine cancer screening in patients with atrial fibrillation because of the low absolute risk of cancer and the potential cost and burden of cancer screening.